Decision Resources, Inc. News
Japan Backs Away from Making Real Changes to Its Rx Pharma Pricing Mechanism
WALTHAM, Mass.,
The most recent proposals do allow for an increase in premiums that can be awarded. For innovative drugs, the premium range will be increased.
"To qualify for this premium in
The 2008 changes also herald the next round of biannual price cuts. There will likely be extraordinary price cuts for big-selling products, specifically products for which sales have significantly exceeded original (official) sales projections. Likely targets will be angiotensin II antagonists and SSRIs.
About Macroview from Decision Resources
Macroview is the most up-to-date analysis on events impacting the healthcare industry. The Macroview updates are part of Decision Resources' Pharmaview product line, which offers a thorough analysis of the biopharmaceutical sector from a therapy, industry and company point-of-view.
About Decision Resources
Decision Resources (http://www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact: Elizabeth Marshall Decision Resources, Inc. 781-296-2563 emarshall@dresources.com
SOURCE Decision Resources, Inc.
Search Our News Using Google Search
Can't find what you want? Try using Google:



